natgillin/translations-raw huggingface dataset:
Hvis du tidligere har haft en alvorlig overfølsomhedsreaktion der kaldes ”angioødem”. Symptomerne er kløe, nældefeber, røde pletter på hænderne, fødderne og på halsen hævelser af tungen, rundt om øjnene og læberne, besværligheder med at trække vejret og synkebesvær.
The signs include itching, hives (urticaria), red marks on the hands, feet and throat, swelling of the throat and tongue, swelling around the eyes and lips, difficulty breathing and swallowing
Smertestillende medicin (Nonsteroide antiinflammatoriske drugs (NSAID'er)
• Medicines used to relieve pain and inflammation (e.g. Non-Steroidal Anti-Inflammatory Drugs
Luftveje, thorax og mediastinum
Respiratory, thoracic and mediastinal disorders
i ramiprilgruppen) viste, at gennemsnitsraten hvormed GFR faldt var lavere i ramiprilgruppen, end i placebogruppen; -0,54 (0,66) vs.
The main analysis of patients with the most severe proteinuria (stratum prematurely disrupted due to benefit in ramipril group) showed that the mean rate of GFR decline per month was lower with ramipril than with placebo; -0.54 (0.66) vs. -0.88 (1.03) ml/min/month, p = 0.038.
til råds, før du tager nogen form for medicin.
Ask your doctor or pharmacist for advice before taking any medicine.
Ungarn
Hungary
Det har vist sig, at den antihypertensive effekt opretholdes under langtidsterapi på to år. Pludseligt ophør med ramipril giver ikke et hurtigt og excessivt tilbageslag med stigning i blodtryk
Abrupt discontinuation of ramipril does not produce a rapid and excessive rebound increase in blood pressure.
til 3 dage før påbegyndelse af behandling med TRITACE (se pkt.
If possible, the diuretic should be discontinued 2 to 3 days before beginning therapy with TRITACE (see section 4.4).
i hjertet:
In this leaflet:
Ungarn:
Hungary:
Vejrtrækningsproblemer eller hoste.
• Shortness of breath or a cough.
Pankreatit (rapporter med fatalt udfald med ACEhæmmere er meget sjældent blevet indrapporteret), stigning i pankreasenzymer, tyndtarmsangioødem, øvre abdominalsmerter inklusive gastritis, forstoppelse, tør
Pancreatitis (cases of fatal outcome have been very exceptionally reported with ACE inhibitors), pancreatic enzymes increased, small bowel angioedema,
Alvorlige reaktioner på huden såsom hududslæt, sår i munden, forværring af eksisterende hudsygdomme, rødmen, forekomst af blistere på huden (såsom Stevens-Johnson syndrom, toksisk epidermisk nekrolyse eller erythema multiform)
reddening, blistering or detachment of skin (such as Stevens-Johnson syndrome, toxic epidermal necrolysis or erythema multiform).
ikke er beskrevet i denne indlægsseddel, skal du kontakte din læge eller dit apotek.
If you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Indehaver af markedsføringstilladelsen
MARKETING AUTHORISATION HOLDER
Brug af anden medicin
Taking this medicine
i andet eller tredje trimester anbefales ultralydsscanning af fosterets nyre funktion og kranium. Børn, hvis mødre har taget ACE-hæmmere, bør observeres nøje for hypotension, oliguri og hyperkaliæmi (se punkt 4.3 og 4.4).
Newborns whose mothers have taken ACE inhibitors should be closely observed for hypotension, oliguria and hyperkalaemia (see also sections 4.3 and 4.4).
samtidig med at du anvender TRITACE kan du blive svimmel.
You may feel dizzy, while taking TRITACE.
Feber
• Fever
”Hos patienter, som er stabiliserede med diuretikabehandling, er den anbefalede startdosis 1,25 mg dagligt.
Starting dose In patients stabilized on diuretic therapy, the recommended initial dose is 1.25 mg daily.
A.
P.O.
tage den normale dosis næste gang Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis
• If you miss a dose, take your normal dose when it is next due.
sagen var at harmonisere produktresuméerne, etiketteringen og indlægssedlen - produktresuméerne, etiketteringen og indlægssedlen, som indehaveren af markedsføringstilladelsen har foreslået, er blevet vurderet på baggrund af den
- the Summaries of Products Characteristic, labelling and package leaflet proposed by the Marketing Authorisation Holders has been assessed based on the documentation submitted and the scientific discussion within the Committee,
Zenra 2.5 mg comprimate, Zenra 5 mg comprimate, Zenra 10 mg comprimate
Tritace 2.5 mg comprimate, Tritace 5 mg comprimate, Tritace 10 mg comprimate Zenra 2.5 mg comprimate, Zenra 5 mg comprimate, Zenra 10 mg comprimate
Artralgi
Arthralgia
skal behandling med ACE-hæmmere og AIIRA seponeres øjeblikkeligt, og der bør opstartes en alternativ behandling (se pkt.
When pregnancy is diagnosed, treatment with ACE inhibitors/ AIIRAs should be stopped immediately, and, if appropriate, alternative therapy should be started (see sections 4.3 and 4.6).
SANOFI-AVENTIS AEBE 348, Syngrou Av.
SANOFI-AVENTIS AEBE 348, Syngrou Av. - Building A 176 74 Kallithea Greece
til at slappe af og udvide
• Making your blood vessels relax and widen
Allopurinol, immunosuppressiva, kortikosteroider, procainamid, cytostatika og andre stoffer der kan ændre antallet af blodlegemer:
Allopurinol, immunosuppressants, corticosteroids, procainamide, cytostatics and other substances that may change the blood cell count: Increased likelihood of haematological reactions (see section 4.4).
Hvis du er gravid i anden og tredje trimester (se afsnittet nedenfor om graviditet og amning)
• During the last 6 months of pregnancy (see section below on “Pregnancy and breast-feeding”)
Du bør ikke anvende TRITACE i de første 12 uger af din graviditet, og efter den 13.
TRITACE is not recommended in the first 3 months of pregnancy and may cause serious harm to your baby after 3
til patienter i behandling med diuretika ovenfor.
See also posology on diuretic treated patients above.
serumkalium anbefales hvis samtidig behandling med de ovenfor nævnte midler vurderes passende (se pkt.
If concomitant use of the above mentioned agents is deemed appropriate, regular monitoring of serum potassium is recommended (see section 4.5).
I alle lande, hvor indikationen efter myokardieinfarkt er godkendt, er den anbefalede startdosis 2,5 mg to gange dagligt.
Secondary prevention after acute myocardial infarction In all countries where the post myocardial infarction indication has been approved the initial recommended dose is 2.5 mg twice daily.
Den almindelige startdosis er 1,25 mg én gang dagligt
• The usual starting dose is 1.25 mg once daily.
Almindelige bivirkninger (forekommer hos færre end 1 ud af 10 patienter)
Common (affects less than 1 in 10 people)
Særlige patientgrupper
Special populations
Danmark:
Denmark:
Den tekst, som er vedtaget i arbejdsgruppen vedrørende lægemiddelovervågning for denne advarsel, opmuntrer ikke til eller foreslår anvendelse af ACE-hæmmere under graviditetens første trimester.
The text agreed in the PhVWP of this warning doesn't encourage or propose the use of ACE inhibitors during the first trimester of the pregnancy on the contrary once the pregnancy is detected the prescriber has to stop the use of ACE inhibitors and to change if it is necessary for another antihypertensive agent as soon as possible.
Det anbefales at fordoble dosis til 2,5 mg efter to uger, og siden
Doubling the once daily dose to 2.5 mg after two weeks and then to 5 mg after a further two weeks is recommended.
Behandling efter blodprop
Treatment of high blood pressure
Triatec faible 1,25 mg, gélule Triatec 2.5 mg, gélule Triatec 5 mg, gélule
Triatec faible 1,25 mg, gélule Triatec 2.5 mg, gélule
Sjældne bivirkninger (forekommer hos færre end 1 ud af 1.000 patienter):
Rare (affects less than 1 in 1,000 people)
De kan nemlig øge virkningen af TRITACE:
They may be affected by TRITACE:
Brystsmerter, udmattethed
Chest pain, fatigue
Den antihypertensive virkning af en enkelt dosis varer sædvanligvis 24 timer. Den maksimale antihypertensive effekt af fortsat behandling med ramipril ses almindeligvis efter 3
The maximum antihypertensive effect of continued treatment with ramipril is generally apparent after 3 to 4 weeks.
GENEREL KLASSIFIKATION FOR UDLEVERING [Udfyldes nationalt]
GENERAL CLASSIFICATION FOR SUPPLY [To be completed nationally]
5.3 Prækliniske sikkerhedsdata
PRECLINICAL SAFETY DATA
Høreforstyrrelser og ringen for ørerne
• Disturbed hearing and ringing in your ears
Indehaveren af markedsføringstilladelsen har foreslået følgende ordlyd for de terapeutiske indikationer for hjerteinsufficiens:
Regarding the therapeutic indications for heart failure, the MAH proposed the wording: “Treatment of congestive heart failure”.
KLINISKE OPLYSNINGER
CLINICAL PARTICULARS
- Zentiva 1.25mg Ramipril - Zentiva 2.5mg Ramipril - Zentiva 5mg Ramipril
Ramipril - Zentiva 2.5mg Ramipril - Zentiva 5mg Ramipril - Zentiva 10mg
Indikationen “Sekundær profylakse efter myokardieinfarkt hos patienter med hjerteinsufficiens”, som indehaveren af markedsføringstilladelsen har foreslået, er berettiget på basis af:
The MAH proposed indication “Secondary prevention after MI in patients with heart failure” has been justified on the basis of the: Acute Infarction Ramipril Efficacy Study (AIRE).
Den aktive metabolit af ramipril, ramiprilat, kan kun i ringe grad cleares fra cirkulation ved dialyse.
Ramiprilat, the active metabolite of ramipril is poorly removed from the general circulation by haemodialysis.
Hovedpine eller træthedsfornemmelse
• Headache or feeling tired
TRITACE indeholder det aktive lægemiddelstof ramipril.
WHAT TRITACE IS AND WHAT IT IS USED FOR TRITACE contains a medicine called ramipril.
Kardiovaskulær profylakse
Cardiac disorders
Aventis Pharma S.A.
AVENTIS PHARMA
• Svimmelhed.
• Hair loss.
England
UK
Nedsat libido hos mænd og kvinder
• Sexual inability in men, reduced sexual desire in men or women
skal udvides til at omfatte knoglemarvsdepression og andre påvirkninger af blodet.
-Agranulatocytosis: the warning should be expanded to include bone marrow depression and other effects on blood.
Fortæl det altid til lægen eller på apoteket, hvis du bruger anden medicin eller har brugt det for nylig.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription (including herbal medicines).
Estland : Cardace 2.5 mg tabletid, Cardace 5 mg tabletid, Cardace 10 mg tabletid
Estonia : Cardace 2.5 mg tabletid, Cardace 5 mg tabletid, Cardace 10 mg tabletid
til også at omfatte ikke kun behandling hos patienter med nedsat nyrefunktion, men også risiko for efterfølgende nedsat nyrefunktion, risikofaktorer og behov for tidlig seponering.
The CHMP adopted the following wording in order to implement this section: -“ Renal Impairment: the warning should be expanded to include not just treatment in patients with renal impairment but the risk of subsequent renal impairment, risk factors and need for early discontinuation.
LÆGEMIDDELFORM OG INDHOLDSMÆNGDE (PAKNINGSSTØRRELSE)
PHARMACEUTICAL FORM AND CONTENTS
o Ældre patienter Se pkt.
o Elderly patients See section 4.2.
BIVIRKNINGER
UNDESIRABLE EFFECTS
Fald i hvide blodlegemer (inklusiv neutropeni eller agranulocytose), fald i hæmatokrit, fald i hæmoglobin, fald i trombocyttal.
Eosinophilia White blood cell count decreased (including neutropenia or agranulocytosis) , red blood cell count decreased, haemoglobin decreased, platelet count decreased
Patienter der planlægger graviditet bør skiftes til alternativ antihypertensiv behandling, der besidder en etablereret
Unless continued ACE inhibitor therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.
Startdosis: Den anbefalede startdosis er 2,5 mg TRITACE en gang daglig.
Starting dose: The recommended initial dose is 2.5 mg of TRITACE once daily.
SANOFI-AVENTIS S.A.
SANOFI-AVENTIS D.O.O.
Letland: Cardace 2.5 mg tabletes, Cardace 5 mg tabletes, Cardace 10 mg tabletes
Latvia: Cardace 2.5 mg tabletes, Cardace 5 mg tabletes, Cardace 10 mg tabletes
Bulgarien: Tritace 2.5 mg таблетки, Tritace 5 mg таблетки, Tritace 10 mg таблетки
Bulgaria: Tritace 2.5 mg таблетки, Tritace 5 mg таблетки, Tritace 10 mg таблетки
Er du i tvivl, så spørg lægen eller på apoteket.
If you have any questions or are not sure about anything, ask your doctor or pharmacist.
Hud og subkutane væv Udslæt, særligt makulopapulært
Skin and subcutaneous tissue disorders
Industriepark Hoechst D-65926 Frankfurt am Main Tyskland
SANOFI-AVENTIS DEUTSCHLAND GMBH Industriepark Hoechst D-65926 Frankfurt am Main Germany
Symptomerne på overdosering kan være kraftig perifer vasodilation (med kraftig hypotension, shock) bradykardi, elektrolytforstyrrelse og nyreinsufficiens. Patienten bør monitoreres tæt, og behandles symptomatisk og understøttende.
Symptoms associated with overdosage of ACE inhibitors may include excessive peripheral vasodilatation (with marked hypotension, shock), bradycardia, electrolyte disturbances, and renal failure.
Litauen: Cardace 2.5 mg tabletės, Cardace 5 mg tabletės, Cardace 10 mg tabletės
Lithuania: Cardace 2.5 mg tabletės, Cardace 5 mg tabletės, Cardace 10 mg tabletės
Slovenien: Tritace 1.25 mg tablete, Tritace 2.5 mg tablete, Tritace 5 mg tablete, Tritace 10 mg tablete
Slovenia: Tritace 1.25 mg tablete, Tritace 2.5 mg tablete, Tritace 5 mg tablete, Tritace 10 mg tablete
Startdosis Den anbefalede startdosis er 2,5 mg TRITACE en gang daglig.
Starting dose The recommended initial dose is 2.5 mg of TRITACE once daily.
TRITACE anbefalse ikke de første tre måneder af graviditeten, se afsnittet ”Graviditet og amning”
months of pregnancy, see section “Pregnancy and breast-feeding”.
Indtagelse af TRITACE:
Do not take TRITACE:
Hos de fleste patienter ses den antihypertensive effekt fra behandlingsstart med en enkelt dosis 1
In most patients the onset of the antihypertensive effect of a single dose becomes apparent 1 to 2 hours after oral administration.
Hvis dosis ikke kan øges til 2,5 mg to gange daglig, bør behandlingen seponeres. Der er stadig utilstrækkelig erfaring med behandlingen af patienter med alvorlig (NYHA IV) hjerteinsufficiens umiddelbart efter myokardieinfarkt.
Sufficient experience is still lacking in the treatment of patients with severe (NYHA IV) heart failure immediately after myocardial infarction.
Udseende og pakningsstørrelser Tabletter, kapsler, hårde [Udfyldes nationalt]
FURTHER INFORMATION What TRITACE.contains [To be completed nationally] What TRITACE looks like and contents of the pack Tablets, hard capsules [To be completed nationally]
Kontakt din læge eller spørg på apoteket, hvis du har nogen spørgsmål, eller er i tvivl om noget.
You should check with your doctor or pharmacist if you are not sure.
Loavel 1.25mg Kapsler Loavel 2.5mg Kapsler Loavel
Loavel 1.25mg capsules Loavel 2.5mg capsules Loavel 5mg capsules Loavel 10mg capsules
Maksimumdosen er 10 mg dagligt.
The maximal dose is 10 mg daily.
Myokardiel iskæmi inklusive angina pectoris og myokardieinfarkt, takykardi, arrhytmia, palpitationer, perifert ødem.
Myocardial ischaemia including angina pectoris or myocardial infarction,
• Tal med lægen eller apoteket, hvis en bivirkninger bliver værre, eller du får bivirkninger, der ikke er nævnt her.
• If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
De kan nemlig mindske virkningen af TRITACE:
They can make TRITACE work less well:
Ramipril 1.25mg Kapsler Ramipril 2.5mg Kapsler Ramipril
Ramipril 1.25mg capsules Ramipril 2.5mg capsules Ramipril 5mg capsules Ramipril 10mg capsules
Josep Pla 2
SANOFI-AVENTIS S.A. Josep Pla 2
Tritace 1.25 mg tabletten/comprimés/ Tabletten, Tritace 2.5 mg tabletten/comprimés/ Tabletten
Ramace 1.25 mg tabletten/comprimés/ Tabletten , Ramace 2.5 mg tabletten/comprimés/ Tabletten , Ramace 5 mg tabletten/comprimés/ Tabletten
Ikke almindelige bivirkninger (forekommer hos færre end 1 ud af 100 patienter):
Uncommon (affects less than 1 in 100 people)
Forstyrrelse af lugtesansen
• Change in the way things smell
Startdosis Den anbefalede startdosis er 1,25 mg TRITACE en gang daglig.
Starting dose: The recommended initial dose is 1.25 mg of TRITACE once daily.
Sanofi-aventis One Onslow Street Guildford Surrey GU1 4YS UK
Sanofi-aventis One Onslow Street Guildford
Antidiabetika inklusiv insulin:
Antidiabetic agents including insulin: Hypoglycaemic reactions may occur.
Delix 1.25 mg Kapseln, Delix 2.5 mg Kapseln, Delix 5 mg Kapseln, Delix 10 mg Kapseln Vesdil 1.25 mg Kapseln, Vesdil 2.5 mg Kapseln, Vesdil 5 mg Kapseln, Vesdil 1.25 mg Tabletten, Vesdil 2.5 mg Tabletten Vesdil N 2.5 mg Tabletten, Vesdil N 5 mg Tabletten Vedil 5 mg Tabletten
Delix 1.25 mg Kapseln, Delix 2.5 mg Kapseln, Delix 5 mg Kapseln, Delix 10 mg Kapseln Vesdil 1.25 mg Kapseln, Vesdil 2.5 mg Kapseln, Vesdil 5 mg Kapseln, Vesdil 1.25 mg Tabletten, Vesdil 2.5 mg Tabletten
system kan efter den første dosis opleve et særligt stort blodtryksfald.
Patients with a strongly activated renin-angiotensin-aldosterone system may experience an excessive drop in blood pressure following the initial dose.
2970 Hørsholm
DK-2970 Hoersholm
AVENTIS PHARMA DEUTSCHLAND GmbH
AVENTIS PHARMA DEUTSCHLAND GMBH Brüningstraße 50
1-13, Boulevard Romain Roland F-75014 Paris
WINTHROP MEDICAMENTS 1-13, Boulevard Romain Roland F-75014 Paris
Indehaver af markedsføringstil- (Lokalt) Navn ladelsen
Marketing Authorisation Holder (Invented) name
Halsbrand, forstoppelse eller mundtørhed
• Heartburn, constipation or dry mouth
LISTE OVER HJÆLPESTOFFER [Udfyldes nationalt]
LIST OF EXCIPIENTS [To be completed nationally]
AVENTIS PHARMA DEUTSCHLAND GMBH
Czech Republic AVENTIS PHARMA DEUTSCHLAND GMBH Industriepark Höchst
Ramipril var standardbehandling hos 9.200 patienter i et præventivt, placebokontrolleret studie (HOPEstudiet).
A preventive placebo-controlled study (the HOPE-study), was carried out in which ramipril was added to standard therapy in more than 9,200 patients.
Slovakiet
Slovak Republic
5.2 TRITACE skal synkes med væske.
TRITACE has to be swallowed with liquid.
5.2 Farmakokinetiske egenskaber
PHARMACOKINETIC PROPERTIES
i hjertet (myocardie infarkt) og hjertesvigt.
• As treatment following heart attack (myocardial infarction) complicated with heart failure.
SÅDAN SKAL DU TAGE TRITACE
HOW TO TAKE TRITACE
slagtilfælde eller perifer vaskulær sygdom i anamnesen) eller o Diabetes med mindst én kardiovaskulær risikofaktor (se pkt.
- Cardiovascular prevention: reduction of cardiovascular morbidity and mortality in patients with: o manifest atherothrombotic cardiovascular disease (history of coronary heart disease or stroke, or peripheral vascular disease) or o diabetes with at least one cardiovascular risk factor (see section 5.1).
I betragtning af de tilgængelige data vedtog CHMP følgende indikation: ”Sekundær profylakse efter akut myokardieinfarkt:
Considering the available data the CHMP adopted the following indication: “Secondary prevention after acute myocardial infarction: reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started >48 hours following acute myocardial infarction”.
Boulevard de la Plaine, 9 B-1050 Bruxelles
Belgium Aventis Pharma S.A. Boulevard de la Plaine, 9
Muskelkramper eller muskelsmerter
• Cramps or pain in your muscles
Slovakiet: Tritace 1.25 mg tablety, Tritace 2.5 mg tablety, Tritace 5 mg tablety, Tritace 10 mg tablety
Slovak Republic: Tritace 1.25 mg tablety, Tritace 2.5 mg tablety, Tritace 5 mg tablety, Tritace 10 mg tablety
4.7 Virkning på evnen
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Lægen har ordineret TRITACE til dig personligt.
• This medicine has been prescribed for you.
Tritace og tilknyttede navne kan bruges som monoterapi eller
Tritace and associated names may be used in monotherapy or in combination with other classes of antihypertensive medicinal products.
inden du begynder at tage medicinen.
Read all of this leaflet carefully before you start taking this medicine.
Startdosis
Starting dose
Den almindelige dosis er 10 mg dagligt.
• The usual dose is 10 mg daily.
TRITACE og associerede navne (se bilag I) 1.25 mg tabletter TRITACE og associerede navne (se bilag I) 2.5 mg tabletter TRITACE og associerede navne (se bilag I) 5 mg tabletter TRITACE og associerede navne (se bilag I) 10 mg tabletter
TRITACE and associated names (see Annex I) 1.25 mg tablets TRITACE and associated names (see Annex I) 2.5 mg tablets TRITACE and associated names (see Annex I) 5 mg tablets TRITACE and associated names (see Annex I) 10 mg tablets
Negle problemer (f.eks. at de løser
• Nail problem (e.g. loosening or separation of a nail from its bed)
sandsynligvis opstartet på en dosis på 1,25 mg eller 2,5 mg én gang dagligt Din læge vil herefter justere din dosis
• You may be started on a dose of 1.25 mg or 2.5 mg once daily.
D-65926 Frankfurt am Main Tyskland
DEUTSCHLAND GmbH 65926 Frankfurt am Main Germany
− Patienter planlagt
Diuretic-Treated patients
Vær ekstra forsigtig med at tage TRITACE Tal med din læge eller apoteket, hvis du:
Check with your doctor or pharmacist before taking your medicine:
RAMIPRIL WINTHROP 1.25 MG RAMIPRIL WINTHROP 2.5 MG, COMPRIME SECABLE
RAMIPRIL WINTHROP 1.25 MG RAMIPRIL WINTHROP 2.5 MG, COMPRIME SECABLE RAMIPRIL WINTHROP 5 MG, COMPRIME SECABLE RAMIPRIL WINTHROP 10 MG, COMPRIME SECABLE
• Lysskyhed
PACKAGE LEAFLET
4.9 Overdosering
OVERDOSE
TRITACE og associerede navne (se bilag I) 1.25 mg hårde kapsler TRITACE og associerede navne (se bilag I) 2.5 mg hårde kapsler TRITACE og associerede navne (se bilag I) 5 mg hårde kapsler TRITACE og associerede navne (se bilag I) 10 mg hårde kapsler [Se bilag I - Udfyldes nationalt]
TRITACE and associated names (see Annex I) 1.25 mg hard capsules TRITACE and associated names (see Annex I) 2.5 mg hard capsules TRITACE and associated names (see Annex I) 5 mg hard capsules TRITACE and associated names (see Annex I) 10 mg hard capsules [See Annex I - To be completed nationally]
Hvis du oplever bivirkninger der
POSSIBLE SIDE EFFECTS
Forvirring
Conjunctivitis
Hvide ”døde” fingre og tæer (Raynaud's phenomen)
• Fingers and toes changing colour when you are cold and then tingling or feeling painful when you warm up (Raynaud's phenomenon)
Får dine blodkar
• Pain in your joints
TRITACE og associerede navne (se bilag I) 1.25 mg hårde kapsler TRITACE og associerede navne (se bilag I) 2.5 mg hårde kapsler TRITACE og associerede navne (se bilag I) 5 mg hårde kapsler TRITACE og associerede navne (se bilag I) 10 mg hårde kapsler
TRITACE and associated names (see Annex I) 1.25 mg hard capsules TRITACE and associated names (see Annex I) 2.5 mg hard capsules TRITACE and associated names (see Annex I) 5 mg hard capsules TRITACE and associated names (see Annex I) 10 mg hard capsules
Lithauen
Lithuania
A-1037 Wien
B-1050 Bruxelles
5.1 Farmakodynamiske egenskaber
PHARMACODYNAMIC PROPERTIES
Ramipril 1.25mg Tabletter Ramipril 2.5mg Tabletter Ramipril
Ramipril 1.25mg tablets Ramipril 2.5mg tablets Ramipril 5mg tablets Ramipril 10mg tablets
Et eller flere lokale produktresuméer indeholder kontraindikationer. Sammenfattende skal graviditet og amning ændres i overensstemmelse med anbefalinger for ACE-I fra arbejdsgruppen vedrørende lægemiddelovervågning.
In summary, pregnancy and lactation should be amended in line with PhVWP recommendations on ACE-I The following should be added to the contraindication:
i kombination med andre klasser af lægemidler mod hypertension”.
Tritace and associated names may be used in monotherapy or in combination with other classes of antihypertensive medicinal products”.
Medicin der kan øge indholdet af kalium i blodet såsom spironolakton, triamterene, amilorid, kalium salteog heparin (blodfortyndende middel)
triamterene, amiloride, potassium salts and heparin (for thinning blood)
(se punkt 4.3).
(See also 5.3 'Preclinical safety data').
Triatec 1.25 mg tabletter, Triatec 2.5 mg tabletter, Triatec 5 mg tabletter, Triatec 10 mg kapsler, hårde
Triatec 1.25 mg tabletter, Triatec 2.5 mg tabletter, Triatec 5 mg tabletter, Triatec 10 mg kapsler
Mavepine, diarré, fordøjelsesbesvær, kvalme, opkast
• Stomach or gut pain, diarrhoea, indigestion, feeling or being sick